首页 | 本学科首页   官方微博 | 高级检索  
     


Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma
Authors:Sekwon Jang MD  Chaoyi Zheng MS  Huei‐Ting Tsai PhD  Alex Z. Fu PhD  Ana Barac MD  PhD  Michael B. Atkins MD  Andrew N. Freedman PhD  Lori Minasian MD  Arnold L. Potosky PhD
Affiliation:1. Division of Oncology, Inova Dwight and Martha Schar Cancer Institute, Fairfax, Virginia;2. Department of Biostatistics, Bioinformatics, and Biomathematics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;3. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC;4. Division of Cardiology, MedStar Washington Hospital Center, Washington, DC;5. Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland;6. Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland
Abstract:
Keywords:cardiovascular toxicity  renal cell carcinoma  sorafenib  stroke  sunitinib
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号